Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kristi L. Lenz"'
Autor:
Anne M. McDonnell, Kristi L Lenz
Publikováno v:
Annals of Pharmacotherapy. 41:86-94
Objective: To assess the efficacy, toxicity, and potential cost benefit of palifermin in the prevention of chemotherapy- and radiation-induced mucositis. Data Sources: MEDLINE and PubMed database searches were conducted (1966–May 2006) using the fo
Autor:
Kristi L Lenz
Publikováno v:
Journal of Pharmacy Practice. 12:178-185
Complementary and alternative medicine (CAM) is gaining in popularity, with one in three Americans reporting some use. The government has taken an interest in CAM research, establishing the National Center for Complementary and Alternative Medicine.
Autor:
Eileen M. Marley, Kristi L Lenz
Publikováno v:
Journal of Pharmacy Practice. 11:349-373
Of the over one million patients diagnosed with cancer each year, 30 percent will have pain at diagnosis and up to 85 percent will have pain as their disease progresses. Adequate pain management continues to be hindered by multiple patient-and clinic
Autor:
Amy W. Valley, Kristi L Lenz
Publikováno v:
Journal of Oncology Pharmacy Practice. 2:75-100
Purpose. Infertility as a late complication of cancer chemotherapy, focusing on specific drug-related ef fects, effects observed in the treatment of certain malignancies, and strategies for prevention is re viewed. Data Sources. A MEDLINE search of a
Publikováno v:
Journal of Oncology Pharmacy Practice. 4:202-204
Autor:
Umberto Veronesi, Edith A. Perez, Judy Garber, Stefan Glück, James J. Vredenburgh, Eric Winer, Gabriel N. Hortobagyi, Hyman B. Muss, Carolyn Sartor, Eva Rubin, Rayna Kneuper Hall, Roland Holland, Veronique Cocquyt, Giovanni Rosti, Giammaria Fiorentini, Phillip Nicholas Blondeel, Eli Avisar, P. Murali Doraiswamy, Judith Hurley, Amy Pickar Abernethy, Jennie R. Crews, Merce Jorda, Maria Victoria Velasquez, Monica Maria Yepes, Anna Maria Gonzalez Angulo, Charles L. Bennett, Cristiane Takita, Mohamed A Kharfan-Dabaja, Daniel Morgensztern, Deborah O. Heros, Eloy Roman, Lawrence Negret, Gilberto Lopes, Manuel F. Rosado, Steve Fein, Teresa De Cesare, Sakher Abdullah, Ernesto Ayala, Orfirio M. Sanchez, Carlos Silva, Ervin Gonzalez, Jason Brenner, Jorge E. Silva, Humberto Caldera, Swami Padmanabhan, Susan Moreno, Alicia Ceballos, Talia Donenberg, Susanna Quasem, Kristi L. Lenz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca335a9778ba723b70f2690a56016e21
https://doi.org/10.1016/b978-3-437-24260-1.50006-3
https://doi.org/10.1016/b978-3-437-24260-1.50006-3
Publikováno v:
Pharmacotherapy. 26(6)
Rasburicase is currently approved at a dosage of 0.15-0.2 mg/kg once/day for 5 days in pediatric patients with cancer to lower plasma uric acid concentrations and manage tumor lysis syndrome (TLS). Information on rasburicase dosing in adults is limit
Autor:
Alison M Massaro, Kristi L Lenz
Publikováno v:
The Annals of pharmacotherapy. 39(1)
OBJECTIVE: To evaluate the safety and efficacy of aprepitant in the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). DATA SOURCES: MEDLINE and PubMed database searches were conducted from 1966 to May 2004 using the fol
Autor:
Donna S Dunlap, Kristi L Lenz
Publikováno v:
The Annals of pharmacotherapy. 32(3)
OBJECTIVE: To describe the use of a continuous fentanyl infusion in an adult cancer patient. CASE SUMMARY: A 66-year-old white woman diagnosed with metastatic pancreatic carcinoma required hospital admission for pain control after receiving five diff
Autor:
Kristi L Lenz
Publikováno v:
Annals of Pharmacotherapy. 38:1549-1550